Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedThis update reflects a minor website/app revision change for ClinicalTrials.gov (version number increment), with no new or removed information in the trial’s record history table.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedRevision v3.5.0 was added and v3.4.3 was removed; the record now shows updates to Recruitment Status and Study Status.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a new Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 was added to the history and a government operating-status notice was removed; no core study data or status information was modified.SummaryDifference0.9%

- Check85 days agoChange DetectedAdded a site-wide funding notice about government lapse and operating status; updated version to v3.4.1 (replacing v3.4.0); To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.